| Literature DB >> 25140446 |
Lei Wang1, Ziming Yang1, Fenglai Lu1, Jinglei Liu1, Yunfei Song2, Dianpeng Li3.
Abstract
Mogroside IIE is a bitter triterpenoid saponin which is the main component of unripe Luo Han Guo fruit and a precursor of the commercially available sweetener mogroside V. In this study, we developed an enzymatic glycosyl transfer method, by which bitter mogroside IIE could be converted into a sweet triterpenoid saponin mixture. The reactant concentration, temperature, pH and buffer system were studied. New saponins with the α-glucose group were isolated from the resulting mixtures, and the structures of three components of the extract were determined. The structure-taste relationships of these derivatives were also studied together with those of the natural mogrosides. The number and stereoconfiguration of glucose groups present in the mogroside molecules were found to be the main factor to determine the sweet or bitter taste of a compound. The antioxidant and food safety properties were initially evaluated by their radical scavenging ability and via 7 day mice survival tests, respectively. The results showed that the sweet triterpenoid saponin mixture has the same favorable physiological and safety characteristics as the natural mogrosides.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25140446 PMCID: PMC6271920 DOI: 10.3390/molecules190812676
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Transglycosylation rate affected by mogroside IIE/starch concentration ratios.
Figure 2Transglycosylation rate affected by temperature.
Figure 3Transglycosylation rate affected by pH.
Figure 4Product changes detected by HPLC-MS.
Figure 5Structure of compounds 1–3 and other mentioned natural mogrosides.
IC50 values of free radical scavenging tests a.
| Tests | MSP | Mogroside V |
|---|---|---|
| Hydroxyl Radicals | 0.202 | 0.139 |
| Superoxide Radicals | 1.260 | 0.551 |
| DPPH | 0.954 | 0.433 |
a Calculated by nonlinear fitting under condition of R2 > 0.99.
Serum biochemical and organ weight data after acute toxicity tests.
| Parameters | Treated Group | Control Group | ||
|---|---|---|---|---|
| Male | Female | Male | Female | |
| ALT (U/L) | 30.1 ± 4.9 | 25.6 ± 3.1 | 27.3 ± 3.6 | 26.0 ± 2.7 |
| AST (U/L) | 55.8 ± 7.2 | 59.4 ± 5.5 | 52.3 ± 6.1 | 56.1 ± 6.5 |
| CRE (mmol/L) | 42.7 ± 10.4 | 37.9 ± 8.3 | 43.8 ± 9.9 | 39.6 ± 10.0 |
| BUN (mmol/L) | 6.5 ± 1.2 | 6.8 ± 1.5 | 6.3 ± 1.8 | 6.6 ± 1.7 |
| Liver Weight (g) | 2.92 ± 0.087 | 1.55 ± 0.051 | 2.93 ± 0.107 | 1.57 ± 0.079 |
| Kidney Weight (g) | 0.60 ± 0.022 | 0.34 ± 0.032 | 0.58 ± 0.048 | 0.34 ± 0.035 |
| Spleen Weight (g) | 0.09 ± 0.004 | 0.10 ± 0.003 | 0.10 ± 0.006 | 0.10± 0.004 |
| Body Weight at the Beginning (g) | 29.5 ± 2.7 | 24.1 ± 2.6 | 29.5 ± 2.6 | 24.0 ± 2.8 |
| Body Weight at the End (g) | 32.7 ± 5.1 | 27.6 ± 6.3 | 32.5 ± 6.0 | 28.0 ± 5.9 |